PuraPharm Corporation Company Description

PuraPharm Corporation Limited, an investment holding company, engages in research, development, production, and sale of concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally.

It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation.

The company offers over the counter health products under the PuraGold, Oncozac, Haveron, and Immuzac brand names.

It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong’s name that provide Chinese medicine services and CCMG products.

In addition, the company engages in the plantation and trading of raw Chinese herbs; manufacture and sale of traditional Chinese medicine decoction pieces; provision of modernized Chinese medicine services, Chinese medical diagnostic, and marketing consultation services; and research and development of bio-based polymeric materials.

The company sells its products to hospitals, healthcare institutions, mobile clinics, and medicine practitioners, as well as operates an online platform.

The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.

PuraPharm Corporation Limited

Country	Cayman Islands
Founded	1998
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	479
CEO	Yu Ling Chan

Contact Details

Address: Wireless Centre, Phase One Tai Po Hong Kong
Phone	852 2840 1840
Website	purapharm.com

Stock Details

Ticker Symbol	1498
Exchange	Hong Kong Stock Exchange
Fiscal Year	January - December
Reporting Currency	HKD
ISIN Number	KYG7306Y1044
SIC Code	2834

Key Executives

Name	Position
Yu Ling Chan	Founder, Chairman and Chief Executive Officer
Yee Wai Man B.Sc., BBS, M.B.A., MBA	Executive Director
Charmayne Chan C.S., CGP	Company Secretary
Jian Zhou	Nanning Production Director